Alterola Biotech Stock Price, News & Analysis
Company Description
Alterola Biotech (OTC Link: ABTI) is a publicly traded drug manufacturers - specialty & generic company in the Healthcare sector. The company has a market capitalization of $7.4M.
ABTI stock has gained 27.5% over the past year. Shares last traded at $0.0051.
On a trailing twelve-month basis, Alterola Biotech reported net income of -$2.4M.
This page provides a comprehensive overview of ABTI stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Alterola Biotech (ABTI) stock last traded at $0.0051. Over the past 12 months, the stock has gained 27.5%. At a market capitalization of $7.4M, ABTI is classified as a micro-cap stock with approximately 1.5B shares outstanding.
Latest News
Alterola Biotech has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 3 with negative movement. Key topics include management, acquisition. View all ABTI news →
SEC Filings
Financial Highlights
operating income reached -$2.1M, and net income was -$2.4M. The company generated -$1.4M in operating cash flow. With a current ratio of 0.00, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Short interest in Alterola Biotech (ABTI) currently stands at 10 shares, representing 0.0% of the float. Over the past 12 months, short interest has decreased by 94.7%. This relatively low short interest suggests limited bearish sentiment. With 1000.0 days to cover, it would take significant time for short sellers to close their positions based on average trading volume.
Days to Cover History
Days to cover for Alterola Biotech (ABTI) currently stands at 1000.0 days, up 99899% from the previous period. This elevated days-to-cover ratio indicates it would take over two weeks of average trading volume for short sellers to exit their positions, suggesting potential for a short squeeze if positive news emerges. The days to cover has increased 99899% over the past year, indicating either rising short interest or declining trading volume. The ratio has shown significant volatility over the period, ranging from 1.0 to 1000.0 days.
ABTI Company Profile & Sector Positioning
Alterola Biotech (ABTI) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing ABTI often look at related companies in the same sector, including Canaquest Medica (CANQF), Hempamericana (HMPQ), Indoor Harvest (INQD), Arev Life Sciences Global Corp (AREVF), and Lowell Farms (LOWLF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate ABTI's relative position within its industry.